PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)

NCT02882828 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Allograft

Interventions

DRUG: switched from Prograf® to Envarsus®

Sponsor

University Hospital, Limoges